HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chong Shen Selected Research

Antipsychotic Agents (Antipsychotics)

1/2021Association Between ApoA1 Gene Polymorphisms and Antipsychotic Drug-Induced Dyslipidemia in Schizophrenia.
1/2018Association of Serum Trace Elements with Schizophrenia and Effects of Antipsychotic Treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chong Shen Research Topics

Disease

24Hypertension (High Blood Pressure)
01/2022 - 08/2007
14Neoplasms (Cancer)
08/2022 - 02/2012
11Stroke (Strokes)
08/2022 - 01/2013
11Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 05/2012
11Type 2 Diabetes Mellitus (MODY)
01/2019 - 01/2012
8Ischemic Stroke
01/2022 - 03/2013
8Genetic Predisposition to Disease (Genetic Predisposition)
01/2021 - 01/2015
5Colitis
12/2008 - 07/2004
5Crohn Disease (Crohn's Disease)
12/2008 - 10/2002
4Atherosclerosis
08/2022 - 01/2020
4Obesity
10/2021 - 02/2012
4Schizophrenia (Dementia Praecox)
01/2021 - 05/2015
4Coronary Disease (Coronary Heart Disease)
01/2021 - 03/2012
4Hemorrhagic Stroke
12/2019 - 08/2017
4Essential Hypertension
11/2019 - 11/2009
4Secondary Hyperparathyroidism
12/2018 - 01/2016
3Overweight
01/2022 - 10/2013
3Osteoarthritis
11/2021 - 01/2018
3Urinary Bladder Neoplasms (Bladder Cancer)
07/2021 - 01/2020
3Dyslipidemias (Dyslipidemia)
01/2021 - 05/2018
3Drug-Related Side Effects and Adverse Reactions
01/2021 - 01/2012
3Chronic Renal Insufficiency
12/2018 - 01/2016
3Inflammation (Inflammations)
01/2018 - 03/2007
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2016 - 02/2012
3Rheumatoid Arthritis
08/2006 - 06/2005
2Lung Neoplasms (Lung Cancer)
08/2022 - 12/2020
2Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2021
2Vascular Remodeling
01/2020 - 01/2014
2Carcinogenesis
01/2020 - 10/2014
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2019 - 01/2013
2Methylmalonic acidemia
10/2016 - 03/2012
2Fatty Liver
06/2016 - 07/2009
2Insulin Resistance
01/2016 - 05/2015
2Abdominal Obesity
01/2016 - 02/2012
2Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets)
01/2016 - 01/2016
2Myocardial Infarction
03/2013 - 01/2013
2Edema (Dropsy)
08/2006 - 07/2004
1Prostatic Neoplasms (Prostate Cancer)
08/2022
1Prehypertension
01/2022
1Coinfection
07/2021
1Renal Cell Carcinoma (Grawitz Tumor)
01/2021

Drug/Important Bio-Agent (IBA)

9LipidsIBA
01/2022 - 02/2012
8Particulate MatterIBA
01/2022 - 01/2019
7ORALIT (ORS)IBA
01/2022 - 01/2012
7Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2015
7Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2009
7Messenger RNA (mRNA)IBA
01/2021 - 03/2007
6HDL CholesterolIBA
12/2019 - 02/2012
6Glucose (Dextrose)FDA LinkGeneric
06/2019 - 02/2012
5Triglycerides (Triacylglycerol)IBA
01/2022 - 02/2012
5C-Reactive ProteinIBA
11/2019 - 05/2012
5Transforming Growth Factor-beta Type II ReceptorIBA
01/2019 - 09/2012
4CholesterolIBA
01/2022 - 06/2016
4Calcitriol Receptors (Calcitriol Receptor)IBA
08/2018 - 09/2014
3MicroRNAs (MicroRNA)IBA
08/2022 - 01/2019
3oxidized low density lipoproteinIBA
01/2022 - 08/2018
3Circular RNAIBA
07/2021 - 01/2019
3EnzymesIBA
02/2021 - 08/2020
3AcidsIBA
08/2020 - 07/2004
3LDL CholesterolIBA
12/2019 - 10/2015
3Insulin (Novolin)FDA Link
10/2018 - 01/2013
3CytokinesIBA
01/2015 - 10/2002
3Pharmaceutical PreparationsIBA
11/2014 - 07/2009
3Monoclonal AntibodiesIBA
03/2007 - 06/2005
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2006 - 06/2005
2A 17 (A-17)IBA
01/2022 - 08/2021
2Reactive Oxygen Species (Oxygen Radicals)IBA
11/2021 - 05/2012
2TeaIBA
08/2021 - 12/2020
2Interleukin-6 (Interleukin 6)IBA
01/2021 - 12/2008
2Antipsychotic Agents (Antipsychotics)IBA
01/2021 - 01/2018
2Indicators and Reagents (Reagents)IBA
01/2021 - 07/2010
2Insulin-Like PeptidesIBA
01/2020 - 09/2017
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2019 - 02/2012
2Antihypertensive Agents (Antihypertensives)IBA
01/2019 - 01/2014
2Hormones (Hormone)IBA
12/2018 - 10/2014
2BilirubinIBA
09/2018 - 11/2017
2Ethanol (Ethyl Alcohol)IBA
08/2018 - 08/2006
2Apolipoproteins E (ApoE)IBA
01/2018 - 02/2016
2Collagen Type I (Type I Collagen)IBA
11/2016 - 03/2005
2mevalonate kinaseIBA
10/2016 - 03/2012
2Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
10/2016 - 03/2012
2Blood Glucose (Blood Sugar)IBA
06/2016 - 02/2012
2Uric Acid (Urate)IBA
06/2016 - 01/2013
2LeptinIBA
01/2016 - 01/2016
2Fibrillin-1IBA
01/2014 - 06/2011
2AntibodiesIBA
11/2012 - 12/2008
2OxazoloneIBA
03/2007 - 07/2004
2HaptensIBA
03/2007 - 07/2004
2Interferon-gamma (Interferon, gamma)IBA
03/2007 - 10/2002
2PteridinesIBA
01/2007 - 08/2006
2Infliximab (Remicade)FDA Link
01/2006 - 06/2005
1CarcinogensIBA
08/2022
1chromium hexavalent ionIBA
08/2022
1cyclo(Arg-Pro) (CI 4)IBA
01/2022
1SolutionsIBA
07/2021
1ImmunosorbentsIBA
02/2021

Therapy/Procedure

7Therapeutics
08/2022 - 06/2005
4Parathyroidectomy
12/2018 - 01/2016
2Rectal Administration
01/2007 - 08/2006
1Secondary Prevention
03/2021